Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 5
2016 10
2017 8
2018 8
2019 5
2020 8
2021 12
2022 11
2023 17
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.
Bertrand-Chapel A, Caligaris C, Fenouil T, Savary C, Aires S, Martel S, Huchedé P, Chassot C, Chauvet V, Cardot-Ruffino V, Morel AP, Subtil F, Mohkam K, Mabrut JY, Tonon L, Viari A, Cassier P, Hervieu V, Castets M, Mauviel A, Sentis S, Bartholin L. Bertrand-Chapel A, et al. Among authors: mohkam k. Commun Biol. 2022 Oct 7;5(1):1068. doi: 10.1038/s42003-022-03994-6. Commun Biol. 2022. PMID: 36207615 Free PMC article.
Intra-operative peritoneal lavage for colorectal cancer.
Passot G, Mohkam K, Cotte E, Glehen O. Passot G, et al. Among authors: mohkam k. World J Gastroenterol. 2014 Feb 28;20(8):1935-9. doi: 10.3748/wjg.v20.i8.1935. World J Gastroenterol. 2014. PMID: 24616569 Free PMC article. Review.
Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling.
Roger E, Martel S, Bertrand-Chapel A, Depollier A, Chuvin N, Pommier RM, Yacoub K, Caligaris C, Cardot-Ruffino V, Chauvet V, Aires S, Mohkam K, Mabrut JY, Adham M, Fenouil T, Hervieu V, Broutier L, Castets M, Neuzillet C, Cassier PA, Tomasini R, Sentis S, Bartholin L. Roger E, et al. Among authors: mohkam k. Cell Death Dis. 2020 Jan 23;11(1):57. doi: 10.1038/s41419-020-2262-1. Cell Death Dis. 2020. PMID: 31974340 Free PMC article.
Painful Right Inguinal Swelling.
Fanget F, Cotte E, Mohkam K. Fanget F, et al. Among authors: mohkam k. JAMA Surg. 2016 Mar;151(3):285-6. doi: 10.1001/jamasurg.2015.2766. JAMA Surg. 2016. PMID: 26746138 No abstract available.
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis.
Villeret F, Lebossé F, Radenne S, Samuel D, Roche B, Mabrut JY, Leroy V, Pageaux GP, Anty R, Thevenon S, Ahmed SS, Hamilton A, Heil M, Scholtès C, Levrero M, Testoni B, Zoulim F; ECOGREFFE Study Group. Villeret F, et al. JHEP Rep. 2023 Mar 10;5(6):100728. doi: 10.1016/j.jhepr.2023.100728. eCollection 2023 Jun. JHEP Rep. 2023. PMID: 37122357 Free PMC article.
Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study.
Hoogwater FJH, Kuipers H, de Meijer VE, Maulat C, Muscari F, Polak WG, van Hoek B, Jézéquel C, Alwayn IPJ, Ijzermans JNM, Mohkam K, Mabrut JY, Van Vilsteren FGI, Adam JP, Chiche L, Chebaro A, Boleslawski E, Dubbeld J, Murad SD, Rayar M, Porte RJ. Hoogwater FJH, et al. Among authors: mohkam k. BJS Open. 2023 Mar 7;7(2):zrad025. doi: 10.1093/bjsopen/zrad025. BJS Open. 2023. PMID: 37032423 Free PMC article.
End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial-HOPExt.
Pradat P, Pantel S, Maynard M, Lalande L, Thevenon S, Adam R, Allard MA, Robin F, Rayar M, Boleslawski E, Scatton O, Chirica M, Faitot F, Bachellier P, Soubrane O, Mohkam K, Mabrut JY, Lesurtel M. Pradat P, et al. Among authors: mohkam k. Trials. 2023 Jun 6;24(1):379. doi: 10.1186/s13063-023-07402-0. Trials. 2023. PMID: 37280696 Free PMC article. Clinical Trial.
Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapy.
Chouik Y, Erard D, Demian H, Schulz T, Mazard T, Hartig-Lavie K, Antonini T, Mabrut JY, Mohkam K, Rode A, Merle P. Chouik Y, et al. Among authors: mohkam k. Front Immunol. 2023 Jun 12;14:1205997. doi: 10.3389/fimmu.2023.1205997. eCollection 2023. Front Immunol. 2023. PMID: 37377975 Free PMC article.
82 results